Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children

BACKGROUND
1 Introduction to Lipids and Lipoproteins Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
2 The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders Ernst J Schaefer, Fumiyoshi Tsunoda, Margaret Diffenderfer, Eliana Polisecki, Ngoc Thai and Bela Asztalos
3 Utility of Advanced Lipoprotein Testing in Clinical Practice Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
4 The Role of Lipids and Lipoproteins in Atherosclerosis MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA, Wenliang L. Song, MD, Amanda C. Doran, PhD, MD and Kasey C. Vickers, PhD
5 Guidelines for the Management of High Blood Cholesterol Scott M. Grundy, MD and Kenneth R. Feingold, MD
6 Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis Deval Bhatt, M.D. and Lisa Tannock, MD
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM
7 Familial Hypercholesterolemia: Genes and Beyond Bruce A. Warden PharmD, BCPS-AQ Cardiology, Sergio Fazio MD, PhD and Michael D. Shapiro, DO
8 Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment Alan Chait, MD and Savitha Subramanian, MD
9 Rare Genetic Disorders Altering Lipoproteins Michael D. Shapiro, DO
10 Lipodystrophy Syndromes: Presentation and Treatment Baris Akinci, Melis Sahinoz and Elif Oral
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS
11 Diabetes and Dyslipidemia Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
12 Dyslipidemia in Chronic Kidney Disease Lisa Tannock, MD
13 Lipid and Lipoprotein Metabolism in Liver Disease David E. Cohen MD, PhD and Kathleen E. Corey MD MPH, MMSc
14 The Effect of Endocrine Disorders on Lipids and Lipoproteins Kenneth R. Feingold, MD, Eliot A. Brinton, MD, FAHA, FNLA and Carl Grunfeld, MD, PhD
15 The Effect of Inflammation and Infection on Lipids and Lipoproteins Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
16 Medication Induced Changes in Lipid and Lipoproteins Megan Herink, Pharm.D., BCPS and Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS.
17 Obesity and Dyslipidemia Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
18 Management of Dyslipidemia in the Elderly Dan Streja, MD, FRCPC, FACP, FACE, and Elani Streja, Ph.D.
19 Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels Sarah B. Grimes, MD and Robert Wild, MD, MPH, PhD
TREATMENT
20 Approach to the Patient with Dyslipidemia Kenneth R. Feingold, MD
21 Lifestyle Changes: Effect of Diet, Exercise, Functional Food, and Obesity Treatment, on Lipids and Lipoproteins Byambaa Enkhmaa, MD, PhD, MAS, Prasanth Surampudi, MD, PhD, Erdembileg Anuurad, MD, PhD, MAS and Lars Berglund, MD, PhD
22 Cholesterol Lowering Drugs Kenneth R. Feingold, MD
23 Triglyceride Lowering Drugs Kenneth R. Feingold, MD
24 Lipoprotein Apheresis Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
PEDIATRIC LIPIDOLOGY
BACKGROUND
25 Is Atherosclerosis a Pediatric Disease Don P. Wilson, MD, FNLA
26 Fetal and Neonatal Cholesterol Metabolism Laura Woollett and James E Heubi
27 Non-Invasive Imaging in Pediatric Atherosclerosis Damon B. Dixon, MD
28 Genetics and Dyslipidemia Nivedita Patni, MD, Zahid Ahmad, MD and Don P. Wilson, MD, FNLA
SCREENING AND GUIDELINES
29 Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents Stephen R. Daniels, MD, PhD
30 Lipid Screening in Youth Lindsay Eilers, MD and Justin P. Zachariah MD MPH
HYPERCHOLESTEROLEMIA
31 Familial Hypercholesterolemia Amy E. Levenson, MD and Sarah D. de Ferranti, MD, MPH
32 Lysosomal Acid Lipase Deficiency Don P. Wilson, MD, FNLA and Nivedita Patni, MD
33 Sitosterolemia in the Pediatric Population Ann Liebeskind, MD, Amy L. Peterson, MD and Don P. Wilson, MD, FNLA
34 Cerebrotendinous Xanthomatosis Nivedita Patni, MD and Don P. Wilson, MD, FNLA
35 Lipoprotein (a) in Youth Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD
HYPERTRIGLYCERIDEMIA
36 Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents Amy S. Shah, MD MS. and Don P. Wilson, MD, FNLA
37 Secondary Hypertriglyceridemia Piers R Blackett MD, Don P. Wilson, MD, FNLA and Catherine J. McNeal, MD, PhD
38 Combined Dyslipidemia in Children and Adolescents Rae-Ellen W. Kavey, MD, MPH.
TREATMENT
39 Nutritional Management of Pediatric Dyslipidemia Lauren A. Williams, MCN, RD and Don P. Wilson, MD, FNLA
40 Use of Lipid Lowering Medications in Youth Melissa L Miller, PharmD, Chanin C Wright, PharmD. and Brandi Rodriguez, PharmD
41 A Clinical Approach to Aggressive Treatment of Children with Severe Hypertriglyceridemia Alejandro De La Torre, MD, Luke Hamilton, MS and Don P. Wilson, MD, FNLA